Reports for TEVA CANADA LIMITED
Formerly known as ACTAVIS PHARMA COMPANY
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
285 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
3009 (91%)
3305
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
411 (94%)
Reversed:
23 (5%)
436
485 (13%)
40 (14%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2021-12-02 | 2023-01-26 | 150409 |
| TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2020-10-01 | 2020-11-12 | 125476 |
| TEVA-SUMATRIPTAN DF | 25MG | TABLET | Resolved | 2017-08-02 | 2017-09-19 | 18030 |
| TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2026-01-08 | 2026-03-12 | 275518 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2021-02-11 | 2021-02-25 | 133788 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2021-01-28 | 2021-02-25 | 132666 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176845 |
| TEVA-SUMATRIPTAN DF | 25MG | TABLET | Resolved | 2021-03-25 | 2021-04-01 | 136326 |
| TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2025-04-04 | 2025-05-08 | 254127 |
| TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2021-04-29 | 2021-08-24 | 138320 |
| TEVA-SUMATRIPTAN DF | 25MG | TABLET | Resolved | 2022-10-28 | 2022-11-12 | 173028 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2021-04-08 | 2021-05-27 | 137209 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2021-03-04 | 2021-04-01 | 135120 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2023-10-19 | 2024-03-21 | 207551 |
| TEVA-TADALAFIL | 2.5MG | TABLET | Resolved | 2021-05-20 | 2021-05-27 | 139758 |
| TEVA-TADALAFIL | 5MG | TABLET | Resolved | 2021-05-06 | 2021-05-27 | 138910 |
| TEVA-TADALAFIL | 2.5MG | TABLET | Resolved | 2024-04-25 | 2024-09-19 | 226177 |
| TEVA-TADALAFIL | 10MG | TABLET | Resolved | 2021-05-27 | 2021-07-09 | 140042 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2019-11-14 | 2020-01-17 | 98738 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2023-12-07 | 2024-04-18 | 212725 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |
| ACT OLMESARTAN HCT | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| ACT OLMESARTAN HCT | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| ACT OLMESARTAN HCT | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258417 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256082 |
| ACT QUETIAPINE | 300MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258643 |
| ACT QUETIAPINE | 200MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258648 |
| ACT RANITIDINE | 300MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115082 |
| ACT RANITIDINE | 150MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115079 |
| ACT RIZATRIPTAN | 10MG | TABLET | Discontinued | 2021-07-22 | 2021-07-22 | 142912 |
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |
| ACT VENLAFAXINE XR | 150.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65305 |